HTEP working group looks at dossier requirements
This article was originally published in Clinica
The European Medicines Agency's Working Party on Cell-Based Products (CPWP) is holding the first of five meetings scheduled for 2008 on February 14-15. Among its regulatory activities are the development of technical dossier requirements for human tissue-engineered products. The deadline is the second quarter of this year.
You may also be interested in...
Jakavi joins the likes of Actemra in targeting the life-threatening immune reaction which is killing acutely ill COVID-19 patients
As China is poised to supply globally medical products to fight coronavirus, a battle to banish its image of poor product quality is on.
With finite resources, the UK’s regulatory agency responsible for health care products is rapidly addressing COVID-19 medtech issues. But shifting its focus will cause delays elsewhere.